LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION Revision 1 March 21, 2023 TO: Honorable Tom Oliverson, Chair, House Committee on Insurance FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: HB2021 by Oliverson (Relating to applicability of certain insurance laws to pharmacy benefit managers.), As Introduced Estimated Two-year Net Impact to General Revenue Related Funds for HB2021, As Introduced : an impact of $0 through the biennium ending August 31, 2025. The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill. General Revenue-Related Funds, Five- Year Impact: Fiscal Year Probable Net Positive/(Negative) Impact toGeneral Revenue Related Funds2024$02025$02026$02027$02028$0All Funds, Five-Year Impact: Fiscal Year Probable Savings/(Cost) fromRETIRED SCHOOL EMP GROUP INSURANCE989 Probable Savings/(Cost) fromSchool Employees UGIP Trust Fund8552024($11,000,000)($27,000,000)2025($12,000,000)($29,000,000)2026($12,000,000)($31,000,000)2027($13,000,000)($33,000,000)2028($14,000,000)($35,000,000) Fiscal AnalysisThe bill would require a pharmacy benefit manager to comply with the provisions of Insurance Code Chapter 1369 unless the plan is explicitly excluded from the applicability of the provisions or the Commissioner of Insurance determines the provisions to be inapplicable.
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 88TH LEGISLATIVE REGULAR SESSION
Revision 1
March 21, 2023
Revision 1
Revision 1
TO: Honorable Tom Oliverson, Chair, House Committee on Insurance FROM: Jerry McGinty, Director, Legislative Budget Board IN RE: HB2021 by Oliverson (Relating to applicability of certain insurance laws to pharmacy benefit managers.), As Introduced
TO: Honorable Tom Oliverson, Chair, House Committee on Insurance
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: HB2021 by Oliverson (Relating to applicability of certain insurance laws to pharmacy benefit managers.), As Introduced
Honorable Tom Oliverson, Chair, House Committee on Insurance
Honorable Tom Oliverson, Chair, House Committee on Insurance
Jerry McGinty, Director, Legislative Budget Board
Jerry McGinty, Director, Legislative Budget Board
HB2021 by Oliverson (Relating to applicability of certain insurance laws to pharmacy benefit managers.), As Introduced
HB2021 by Oliverson (Relating to applicability of certain insurance laws to pharmacy benefit managers.), As Introduced
Estimated Two-year Net Impact to General Revenue Related Funds for HB2021, As Introduced : an impact of $0 through the biennium ending August 31, 2025. The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill.
Estimated Two-year Net Impact to General Revenue Related Funds for HB2021, As Introduced : an impact of $0 through the biennium ending August 31, 2025. The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill.
The bill would make no appropriation but could provide the legal basis for an appropriation of funds to implement the provisions of the bill.
General Revenue-Related Funds, Five- Year Impact:
2024 $0
2025 $0
2026 $0
2027 $0
2028 $0
All Funds, Five-Year Impact:
2024 ($11,000,000) ($27,000,000)
2025 ($12,000,000) ($29,000,000)
2026 ($12,000,000) ($31,000,000)
2027 ($13,000,000) ($33,000,000)
2028 ($14,000,000) ($35,000,000)
Fiscal Analysis
The bill would require a pharmacy benefit manager to comply with the provisions of Insurance Code Chapter 1369 unless the plan is explicitly excluded from the applicability of the provisions or the Commissioner of Insurance determines the provisions to be inapplicable.
Methodology
According to the Teacher Retirement System of Texas (TRS), Chapter 1369 of the Insurance Code would apply to TRS-Care and TRS-ActiveCare because both healthcare benefits plans contract with a pharmacy benefit manager to administer the prescription drug benefits of those plans. The agency states that the bill would restrict the agency's ability to make changes that are intended to mitigate rapid cost inflation. Subchapter B would prevent mid-year formulary changes and would create new requirements and restrictions for step therapy. Subchapter E would require the agency to set member cost sharing for all cancer drugs at the same level, which would require the agency to lower cost sharing for certain drugs. Subchapter C would prevent formulary restrictions of contraceptives that are FDA approved. Subchapter I would prevent charging pharmacies claims adjudication fees. Additional costs would not increase the statutorily required state contributions to the TRS-Care and TRS-ActiveCare programs for the 2024-25 biennium; therefore, no significant fiscal impact to the General Revenue Fund is anticipated. However, the additional costs may result in the need for additional contributions from the State, employers, or members to the TRS-Care and TRS-ActiveCare programs.According to the Employees Retirement System (ERS), the cost impact to the Group Benefits Program (GBP) for the additional coverage required in the bill cannot be determined.Based on the analysis of the Department of Insurance, Texas A&M University System Administrative & General Offices, and the University of Texas System Administration, duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.
Local Government Impact
No significant fiscal implication to units of local government is anticipated.
Source Agencies: b > td > 323 Teacher Retirement System, 327 Employees Retirement System, 454 Department of Insurance, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration
323 Teacher Retirement System, 327 Employees Retirement System, 454 Department of Insurance, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration
LBB Staff: b > td > JMc, AAL, ASA, MMo, LBl, CMA
JMc, AAL, ASA, MMo, LBl, CMA